Citation: M. Platten et al., Malignant glioma biology: Role for TGF-beta in growth, motility, angiogenesis, and immune escape, MICROSC RES, 52(4), 2001, pp. 401-410
Authors:
Wick, W
Grimmel, C
Wild-Bode, C
Platten, M
Arpin, M
Weller, M
Citation: W. Wick et al., Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta 2, J NEUROSC, 21(10), 2001, pp. 3360-3368
Authors:
Platten, M
Wild-Bode, C
Wick, W
Leitlein, J
Dichgans, J
Weller, M
Citation: M. Platten et al., N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-beta release and reduces migration and invasiveness of human malignant glioma cells, INT J CANC, 93(1), 2001, pp. 53-61
Authors:
Wild-Bode, C
Weller, M
Rimner, A
Dichgans, J
Wick, W
Citation: C. Wild-bode et al., Sublethal irradiation promotes migration and invasiveness of glioma cells:Implications for radiotherapy of human glioblastoma, CANCER RES, 61(6), 2001, pp. 2744-2750
Authors:
Roth, W
Isenmann, S
Nakamura, M
Platten, M
Wick, W
Kleihues, P
Bahr, M
Ohgaki, H
Ashkenazi, A
Weller, M
Citation: W. Roth et al., Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis, CANCER RES, 61(6), 2001, pp. 2759-2765
Authors:
Naumann, U
Kugler, S
Wolburg, H
Wick, W
Rascher, G
Schulz, JB
Conseiller, E
Bahr, M
Weller, M
Citation: U. Naumann et al., Chimeric tumor suppressor 1, a p53-derived chimeric tumor suppressor gene,kills p53 mutant and p53 wild-type glioma cells in synergy with irradiation and CD95 ligand, CANCER RES, 61(15), 2001, pp. 5833-5842
Authors:
Weller, M
Streffer, J
Wick, W
Kortmann, RD
Heiss, E
Kuker, W
Meyermann, R
Dichgans, J
Bamberg, M
Citation: M. Weller et al., Preirradiation gemcitabine chemotherapy for newly diagnosed glioblastoma -A phase II study, CANCER, 91(2), 2001, pp. 423-427
Authors:
Wick, W
Hochberg, F
O'Sullivan, J
Goessling, A
Hughes, A
Cher, L
Citation: W. Wick et al., L-dopa-resistant parkinsonism syndrome following cerebral radiation therapy for neoplasm, ONCOL REP, 7(6), 2000, pp. 1367-1370
Authors:
von Deimling, A
Fimmers, R
Schmidt, MC
Bender, B
Fassbender, F
Nagel, J
Jahnke, R
Kaskel, P
Duerr, EM
Koopmann, J
Maintz, D
Steinbeck, S
Wick, W
Platten, M
Muller, DJ
Przkora, R
Waha, A
Blumcke, B
Wellenreuther, R
Meyer-Puttlitz, B
Schmidt, O
Mollenhauer, J
Poustka, A
Stangl, AP
Lenartz, D
von Ammon, K
Henson, JW
Schramm, J
Louis, DN
Wiestler, OD
Citation: A. Von Deimling et al., Comprehensive allelotype and genetic analysis of 466 human nervous system tumors, J NE EXP NE, 59(6), 2000, pp. 544-558
Authors:
Platten, M
Wick, W
Wild-Bode, C
Aulwurm, S
Dichgans, J
Weller, M
Citation: M. Platten et al., Transforming growth factors beta(1) (TGF-beta(1)) and TGF-beta(2) promote glioma cell migration via up-regulation of alpha(v)beta(3) integrin expression, BIOC BIOP R, 268(2), 2000, pp. 607-611
Authors:
Pohl, U
Wick, W
Weissenberger, J
Steinbach, JP
Dichgans, J
Aguzzi, A
Weller, M
Citation: U. Pohl et al., Characterization of Tu-2449, a glioma cell line derived from a spontaneoustumor in GFAP-v-src-transgenic mice: comparison with established murine glioma cell lines, INT J ONCOL, 15(4), 1999, pp. 829-834
Authors:
Wick, W
Furnari, FB
Naumann, U
Cavenee, WK
Weller, M
Citation: W. Wick et al., PTEN gene transfer in human malignant glioma: sensitization to irradiationand CD95L-induced apoptosis, ONCOGENE, 18(27), 1999, pp. 3936-3943
Citation: M. Stander et al., Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth, CELL TIS RE, 296(2), 1999, pp. 221-227
Authors:
Wick, W
Grimmel, C
Wagenknecht, B
Dichgans, J
Weller, M
Citation: W. Wick et al., Betulinic acid-induced apoptosis in glioma cells: A sequential requirementfor new protein synthesis, formation of reactive oxygen species, and caspase processing, J PHARM EXP, 289(3), 1999, pp. 1306-1312